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antigenemia and development of HIB s p e c i f i c antibody i n serum following onset of a c u t e i l l n e s s . The q u a n t i t a t i v e d i r e c t p l a t i n g method and i n d i r e c t ELISA were used t o determine t h e numb e r of organisms, PRP, and immunoglobulin c l a s s of BIB s p e c i f i c antibody. Bacteremia and antigenemia were detected i n a l l pat i e n t s immediately a f t e r onset of i l l n e s s . Although bacteremia c l e a r e d promptly a f t e r a n t i b i o t i c therapy, PRP could be detected i n serum up t o 96 days a f t e r onset of i l l n e s s . The presence of a low magnitude bacteremia (<300 organismslml) c o r r e l a t e d t o a maximum concentration of 10 ng/ml of PRP. On t h e o t h e r hand, b a c t e r i a l counts of l x 1 0~/ m l c o r r e l a t e d t o >I000 n g / d of PRP. Despite t h i s c o r r e l a t i o n , p e r s i s t e n c e of PRP antigenemia appeared t o b e independent of a ) magnitude of antigenemia observed during t h e a c u t e phase, b) development of antibody, o r c) p a t i e n t ' s age a t time of i l l n e s s . However, serum antibody response was observed i n convalescent samples only i n s u b j e c t s who exhibited peak PRP concentrations < I 0 ng/ml (p=0.006). These f i n d i n g s sugg e s t a d i r e c t c o r r e l a t i o n between t h e magnitudes of bacteremia and antigenemia and t h a t a n t i g e n may p e r s i s t f o r long periods even i n t h e presence of antibody and the l e v e l of antigenemia s i g n i f i c a n t l y influences t h e convalescent antibody response.
REGULATION OF INTERFERON RECEPTOR EXPRESSION ON
1130 HUMAN LYMPHOCYTES. Allan S. Lau, Greg E. Hannigan, Melvin H. Freedman and Bryan R.G. Williams. Spon. by R. Gold). Research I n s t i t u t e , H o s p i t a l f o r Sick Children, Toronto, Ontario.
I n t e r f e r o n s (IEN) e l i c i t a n t i v i r a l and a n t i n e o p l a s t i c a c t i v i ti e s by binding t o s p e c i f i c r e c e p t o r s on the c e l l s u r f a c e . The binding of IFN t o human lymphocytes was studied using IFNa'j (Schering-Plough) l a b e l l e d t o high s p e c i f i c a c t i v i t y with 2 5~. P e r i p h e r a l Blood Lymphocytes CPBL) from 8 a d u l t x a l u n t e e r s and t o n s i l l a r B c e l l s from 4 c h i l d r e n , who underwent e l e c t i v e tonsillectomy, were s t u d i e d . S p e c i f i c 1 2 5~-~~~a 2 binding isotherms were generated on t h e s e c e l l s . When c e l l s were preincubated i n v i t r o w i t h low c o n c e n t r a t i s of unlabelled IFNcr2 f o r 20h, subsequent reduced binding of P'51-IFNa2 was observed. This suggests t h a t IFN r e c e p t o r s on f r e s h l y i s o l a t e d PBL a r e down-regulated i n response t o IFN treatment. The binding of IFN co down-regulated c e l l s gradually returned t o normal, when c e l l s were allowed t o recover i n IFN-free medium. In vivo s t u d i e s were done on PBL of two p a t i e n t s being t r e a t e d with 5 x 1 0~ u n i t s of IFNa2 subcutaneously d a i l y f o r disseminated condyloma acuminata. Binding of i 2 5~-~~~a 2 was monitored p r i o r t o and a f t e r 5 , 9 and 19 days of IFN therapy. Down r e g u l a t i o n of binding was observed 24h a f t e r each dose. Similar s t u d i e s on p a t i e n t s r e c e i v i n g IFN therapy f o r a c u t e lymphoblastic leukemia o r l a r y n g e a l papilloma a r e i n progress. These r e s u l t s should have important implications f o r d i r e c t i n g t h e c l i n i c a l use of IFN.
The Effect of Pseudomonas aeruginosa Mucopolysacharide on Neutrophil Function. DA Lee, GM johnson, cc clawson, PK k t e r s o n , PG k i e .
Pseudomoms aeruoinosa i s a bacterial s~e c i e s freouentlv i s o l a t e d from the l;ngs of c y s t i c f i b r o s i s I C F ) p a t i e i t s . W; used a recently described 'phagocytosis assay t o examine the i n t e r a c t i o n between P. aerug and human neutrophi 1s (PMN). Staphylococcus aureus, a l s o frequently isolated from the CF lung, was used a s a control. A variety of assays were used t o examine the e f f e c t on PMN of a rnucopolysaccharide (slime) produced by P. aerug.
A "surface phagocytosis" assay was used t o determine the uptake of 3H-labeled S. aureus and P. a e m g by PMN. The bacteria were washed vigorously o r l e f t untreated a f t e r 18 hr. growth so t h a t the e f f e c t of slime could be determined when PMN were added. The overall phagccytosis of P. aerug was s i g n i f i c a n t l y l e s s than S. aureus. Opsonization (10% pooled human s e r a ) effected a 25% increase in the uptake of S. aureus a t 15 and 60 min. The uptake of opsonized P. aemcg was increased by 150:: a t 15 min. but was reduced t o the level of increase seen in S. aureus a t 60 min.
Only a moderate decrease in chemotaxis was observed when PMN were t r e a t e d with crude o r purified slime. No difference was seen in che~niluminescence, degranulation, 0 -production, o r LDH release when t r e a t e d PMN were compared t$ untreated PMN.
These data together with electron and l i g h t microscopy suggest t h a t slime and the absence of opsonin in the aveoli may be detrimental t o PMN interaction with P. aerug. The e f f e c t of slime on PMN function appears t o be minor. The immunological adjuvant, Propionibacterium acnes (formerly c l a s s i f i e d a s Corynebacterium parvum) i s believed t o be t h e major f a c t o r i n t h e e t i o l o g y of inflammatory acne (IA). We have previously reported d e f e c t i v e phagocytosis of P. acnes by neut r o p h i l s i n some p a t i e n t s with IA. I n attempting t o e l u c i d a t e t h i s phenomenon we undertook t h e p r e s e n t i n v e s t i g a t i o n t o a s s e s s t h e r e l i a b i l i t y of measuring chemiluminescence (CL) by phagoc y t i z i n g n e u t r o p h i l s a s a t o o l i n d e f i n i n g t h e opsonic requirement of P. acnes.
Neutrophils (PMN), p u r i f i e d through Methocel-isopaque, were mixed with P. acnes o r P. granulosum i n the presence of pooled human serum; Mg-EGTA chelated serum; and heat i n a c t i v a t e d serum.
The r e s u l t s demonstrate t h a t CL i n t e n s i t y i s p r o p o r t i o n a l l y r e l a t e d t o serum concentration, number of PMNs, and b a c t e r i a and PMN r a t i o s . Complement was required f o r e f f i c i e n t opsoniz a t i o n . Additional d a t a r e v e a l t h a t t h e r e a r e q u a l i t a t i v e and q u a n t i t a t i v e d i f f e r e n c e s i n the requirements f o r optimal ingest i o n of P. acnes and P. granulosum. Our d a t a suggest t h a t whereas both t h e c l a s s i c a l and a l t e r n a t i v e pathways a r e operat i v e f o r opsonization of P. acnes, t h e a l t e r n a t i v e pathway prov i d e s opsonic a c t i v i t y equal t o t h a t of t h e t o t a l complement pathway f o r P. granulosum.
We conclude t h a t CL i s an u s e f u l screening method f o r detecti n g impaired opsonization i n p a t i e n t s with IA and f o r monitori n g immune response t o acne therapy i n a very p r e c i s e manner. C l i n i c a l i s o l a t e s from f i v e i n f a n t s who experienced r e c u r r e n t herpes simplex v i r u s (HSV) d i s e a s e following acyclovir therapy f o r neonatal i n f e c t i o n were examined t o determine i f subsequent d i s e a s e was caused by v i r u s r e s i s t a n t t o acyclovir i n v i t r o . A l l i n f a n t s received a t l e a s t two courses of a n t i v i r a l therapy and were f e l t t o improve c l i n i c a l l y during drug a d m i n i s t r a t i o n . Following d i s c o n t i n u a t i o n of a n t i v i r a l therapy however, s i g n s and symptoms of r e c u r r e n t herpesvirus i l l n e s s were p r e s e n t p e r i p h e r a l l y , and i n some cases were associated with systemic c l i n i c a l d e t e r i o r a t i o n . The i n v i t r o s e n s i t i v i t y of v i r u s i s o l a t e d from t h e s e i n f a n t s was determined using a m i c r o t i t e r d y e uptake technique i n Vero c e l l s . S e n s i t i v i t y v a l u e s a r e e x p r e s s e d a s t h e concentration of acyclovir required t o i n h i b i t v i r u sinduced cytbpathic e f f e c t s by 50% (ID value). A l l v i r u s i s o l a t e d from t h e s e i n f a n t s was sensi51ve t o acyclovir. The mean p r e therapy IDSO was 1.37 mcg/ml. Following a f i r s t course of a c y c l o v i r , r e c u r r e n t l e s i o n s were c u l t u r e p o s i t i v e i n only t h r e e of f i v e babies. The mean ID50 of t h e s e i s o l a t e s was 0.96. The of v i r u s i s o l a t e d from recurrences i n a l l f i v e i n f a n t s :%!?owing a d d i t i o n a l intravenous drug therapy was 1.39. Recurrent and progressive d i s e a s e i n t h i s group of i n f a n t s could not be a t t r i b u t e d t o s e l e c t i o n of r e s i s t a n t v i r u s . I n a m u l t i c e n t e r study, 502 normal i n f a n t s ages 7-14 months were randomized t o r e c e i v e e i t h e r 2 doses of PRP-D intramusculakl y containing 20 ug PRP (80%) o r placebo (20%) 6-10 weeks a p a r t . Serum samples were obtained from 25% p r i o r t o each i n j e c t i o n and 1 month post second dose and t e s t e d by Farr-type radioimmunoassay f o r anti-PRP antibody. Reaction d a t a a r e a v a i l a b l e from 400 s u b j e c t s . The incidence of l o c a l erythema a t t h e i n j e c t i o n s i t e was 2.4% and i r r i t a b i l i t y 3% i n both groups. Two PRP-D r e c i p i e n t s had temperatures g r e a t e r than 1 0 2~(~) .
STUDIES OF SAFETY AND IMMUNOGENICITY OF HAEMOPHILUS
Among 120 c h i l d r e n t e s t e d f o r antibody, 99% of PRP-D r e c i p i e n t s demonstrated a two f o l d o r g r e a t e r r i s e i n anti-PRP compared w i t h 5% of placebo r e c i p i e n t s . Median anti-PRP l e v e l s i n t h e two groups were 7.0 and 0.012 ug/ml r e s p e c t i v e l y . After 2 doses of PRP-D, 95% h a d 1 0.15 ug/ml antibody proteinlml and 90% had > 1 uglml. This study confirms p r i o r observations i n 9-14 month o l d s t h a t PRP-D can induce primary and b o o s t e r antibody responses i n i n f a n t s over 7 months compatible with p r o t e c t i o n a g a i n s t H. influenzae b d i s e a s e .
